skip to main content

PPI long-term risk review — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

EasyGastrointestinal TherapeuticsPPI long-term risk reviewGPhC CRA

A patient has taken lansoprazole 30mg daily for several years after a short NSAID course. He has no current reflux symptoms and asks for a repeat supply. What is the most appropriate alternative?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Suggest prescriber review for ongoing indication and possible step-down

Long-term PPI therapy should have a clear ongoing indication and be periodically reviewed. If symptoms are controlled and the original indication has resolved, step-down or stopping may be considered by the prescriber. The pharmacist should not independently escalate or switch therapy.

Reference: NICE CKS; BNF